Xconomy National

Archives

by in

Entry	Author	Date	Location
Vertex, Ariad, Alnylam, & More Boston-Area Life Sciences Newsmakers	Erin Kutz	12/16/11	Boston
Ariad Loads Up With $200M Stock Deal, After Big Medical Meeting	Luke Timmerman	12/15/11	Boston
AMAG Stock Rises, Ariad Drug Shows Improved Safety, Rhythm Adds Merck Veteran as CEO, & More Boston-Area Life Sciences News	Erin Kutz	11/11/11	Boston
Ariad’s Second Cancer Drug Found Safer Than Expected in Early Review of Key Study	Luke Timmerman	11/07/11	Boston
Tokai Gets $23M, Eleven Therapeutics Hires New CEO, Ariad Drug Advances, & More Boston-Area Life Sciences News	Erin Kutz	09/23/11	Boston
Ariad Brings Third Cancer Drug Into Human Trials	Arlene Weintraub	09/22/11	Boston
Merck Submits Ariad Drug to EU	Luke Timmerman	08/01/11	Boston
Aria Shows Drug Data at ASCO, Pfizer Supports Selecta, WPI Adds Big Pharma Partners, & More Boston-Area Life Sciences News	Erin Kutz	06/10/11	Boston
ASCO Wrap-Up: The Skinny on Cancer News From All Corners of the U.S.	Luke Timmerman	06/07/11	National
Ariad and Infinity to Reveal Data at ASCO, Excelimmune Gets $10.5M, Hologic Buys TCT, & More Boston-Area Life Sciences News	Erin Kutz	06/03/11	Boston
Ariad Eagerly Awaits the Big Show, ASCO, To Display Cancer Trial Results	Luke Timmerman	05/31/11	Boston
Ariad Extends Licenses, Amgen Osteoporosis Drug Meets Trial Goals, Corindus Partners with Philips, & More Boston-Area Life Sciences News	Erin Kutz	04/22/11	Boston
Ariad Extends Three Tech Licensing Deals	Ryan McBride	04/20/11	Boston
Harvest Power Gets $52M, Zynga Buys Floodgate, Synageva Snaps Up $25M, & More Boston-Area Deals News	Erin Kutz	03/23/11	Boston
Alnylam Settles One Lawsuit, Hit With Another; Living Proof Raises $16M, Tolerx/GSK Drug Fails to Meet Goal, & More Boston-Area Life Sciences News	Rebecca Zacks	03/18/11	Boston
Ariad Opts to Sell Cancer Drug with Merck	Ryan McBride	03/17/11	Boston
Ariad Pharma Stock Up More than 25 Percent on Positive Phase III Data	Ryan McBride	01/18/11	Boston
Antigenics Expands Experimental Cancer Treatment, Novartis Adds to Cambridge Presence, Boston Scientific Sells Unit to Stryker, & More Boston-Area Life Sciences News	Erin Kutz	10/29/10	Boston
5 Biotech Storylines to Watch in Boston	Ryan McBride	10/13/10	Boston
Sanofi-Aventis Backs Mass Life Sciences Center, Redline Raises $7.45M, Swipely Launches with $7.5M, & More Boston-Area Deals News	Erin Kutz	05/12/10	Boston
Icahn Blasts Genzyme Manufacturing, Glaxo Halts “Red Wine” Drug Trial, Ariad Gets $69M from Merck, & More Boston-Area Life Sciences News	Erin Kutz	05/07/10	Boston
Ariad Gets $69M in Revised Merck Deal	Ryan McBride	05/05/10	Boston
The Boston Biotech Survival Index: Big Fish Still Swimming, Minnows Getting Eaten	Luke Timmerman	10/08/09	Boston
Akamai And Delve Dig Into Online Video, Cardiorobotics Snags $11.6M for Snake-Like Surgery Robot, Longworth Collects $122M, & More Boston-Area Deals News	Rebecca Zacks	08/07/09	Boston
Biotech Startup Acetylon Pharma Catches $7.25M in A Round from Backers Such As New England Patriots Owner	Ryan McBride	08/07/09	Boston
Ariad Raises $30.9M	Luke Timmerman	08/04/09	Boston
Joule Debuts Biofuel Technology, Genzyme Cleans House, Avila Banks $30M, & More Boston-Area Life Sciences News	Rebecca Zacks	07/29/09	Boston
Ariad Shares Boom as Cancer Drug Shows Promise	Luke Timmerman	07/28/09	Boston
Vertex Puts up $375M for ViroChem, Nuance Finally Nabs Zi, Proteon Procures $38M, & More Boston-Area Deals News	Rebecca Zacks	03/06/09	Boston
Synta Melanoma Drug Trial Halted, Drug Regulators Hand Genzyme Mixed Bag, Ariad and ImmunoGen Reach Milestones, & More Boston-Area Life Sciences News	Rebecca Zacks	03/04/09	Boston
Page 1 of 2	next page »